Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic Syndrome is an Independent Risk Factor for Fuhrman Grade and TNM Stage of Renal Clear Cell Carcinoma
Qian Zhang, Peng Chen, Renli Tian, et al.
International Journal of General Medicine (2022) Vol. Volume 15, pp. 143-150
Open Access | Times Cited: 10

Showing 10 citing articles:

Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies
Valentina Schiavoni, Roberto Campagna, Valentina Pozzi, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3207-3207
Open Access | Times Cited: 35
Prediction Performance of Deep Learning for Colon Cancer Survival Prediction on SEER Data
Surbhi Gupta, S. Kalaivani, R Archana, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 33
Integrating machine learning and single-cell sequencing to identify shared biomarkers in type 1 diabetes mellitus and clear cell renal cell carcinoma
Yi Li, Rui Zeng, Yuhua Huang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Can Diet Prevent Urological Cancers? An Update on Carotenoids as Chemopreventive Agents
Tomasz Konecki, Aleksandra Juszczak, Marcin Cichocki
Nutrients (2022) Vol. 14, Iss. 7, pp. 1367-1367
Open Access | Times Cited: 8
The effect of metabolic syndrome on prognosis of diffuse large B-cell lymphoma
Wenjing Xiong, Liru Li, Hui Xue, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 9, pp. 2240-2249
Open Access | Times Cited: 1
Predicting the prognosis of patients with renal cell carcinoma based on the systemic immune inflammation index and prognostic nutritional index
Weiming Ma, Wei Liu, Dong Yang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Influence of metabolic syndrome on survival of patients with localized renal clear cell carcinoma: A retrospective cohort study in China
Ying Liang, Chengguo Zhang, Jun Luo, et al.
Urologic Oncology Seminars and Original Investigations (2023) Vol. 41, Iss. 5, pp. 257.e19-257.e26
Open Access | Times Cited: 3
Preoperative Metabolic Syndrome and HDL-C Level Predict the Prognosis of Patients Following Radical Cystectomy: A Propensity Score Matching Study
Zenan Liu, Hai Bi, Wei He, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Metabolisches Syndrom und Krebsrisiko
Hans Scherübl
DMW - Deutsche Medizinische Wochenschrift (2022) Vol. 147, Iss. 16, pp. 1068-1077
Closed Access | Times Cited: 3
The Incidence of Renal Cell Carcinoma Is Increased in Patients With Obstructive Sleep Apnea
Hyoung Keun Park, Woo Suk Choi, Jae Hoon Cho
Sleep Medicine Research (2022) Vol. 13, Iss. 2, pp. 81-84
Open Access | Times Cited: 1
Page 1

Scroll to top